A research team at Leibniz-HKI has described a new enzyme that renders the highly toxic molecule malleicyprol harmless.
Researchers have captured real-time "molecular movies" showing how an enzyme changes shape during catalysis. The study was ...
Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular snapshots of human polynucleotide phosphorylase (hPNPase) in action, ...
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
In a groundbreaking study, researchers have captured real-time "molecular movies" showing how an enzyme changes shape during catalysis. Using an ...
PRESS RELEASEAB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES AND CHARACTERIZES A NOVEL SMALL SYNTHETIC MOLECULE, AB8939, AS A ...
Mineralys (MLYS) is transitioning to a pre-commercial stage, supported by robust Phase 3 data and a strengthened cash ...
Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.
Australian researchers have worked with global phamarceutical company MSD to co-develop a new antimalarial drug candidate ...
Your "roommate's" genes could be influencing the bacteria living in your gut, and vice versa, according to a study of rats ...